Targeting Deregulated Apoptotic and Transcriptional Programs in Lymphoma

$296,604P01FY2006CANIH

Dana-Farber Cancer Inst, Boston MA

Investigators

Loren D Walenskycontact

Linked publications & trials

Paper 33976133 Paper 26773040 Paper 25921526 Paper 25468432 Paper 23974956 Paper 23801563 Paper 23764004 Paper 23382223 Paper 23243274 Paper 23230272 Paper 23079663 Paper 23001146 Paper 23001145 Paper 22999885 Paper 22975378 Paper 22897848 Paper 22891273 Paper 22623730 Paper 22622039 Paper 22511926 Paper 22382893 Paper 22355706 Paper 22343534 Paper 22341456 Paper 22308491 Paper 22137796 Paper 22113614 Paper 22077063 Paper 22039264 Paper 21962511 Paper 21921781 Paper 21804550 Paper 21635249 Paper 21390126 Paper 21282644 Paper 21258420 Paper 21245310 Paper 21219174 Paper 21168768 Paper 21156282 Paper 21156281 Paper 21075307 Paper 20844565 Paper 20812997 Paper 20728025 Paper 20628145 Paper 20562877 Paper 20332322 Paper 20142431 Paper 20133803 Paper 20133637 Paper 20010689 Paper 19965633 Paper 19917837 Paper 19879843 Paper 19855081 Paper 19818714 Paper 19706818 Paper 19704259 Paper 19587764 Paper 19412164 Paper 19344412 Paper 19204108 Paper 19174520 Paper 19117530 Paper 19064702 Paper 19036086 Paper 18829491 Paper 18775323 Paper 18754031 Paper 18729853 Paper 18663224 Paper 18603135 Paper 18603134 Paper 18599436 Paper 18513936 Paper 18316419 Paper 18292225 Paper 18158901 Paper 18094406 Paper 18006696 Paper 17713479 Paper 17697968 Paper 17637749 Paper 17560275 Paper 17363542 Paper 17360630 Paper 17360556 Paper 17170253 Paper 17052454 Paper 16782029 Paper 16778141 Paper 16767092 Paper 16754847 Paper 16728701 Paper 16707591 Paper 16651521 Paper 16645094 Paper 16492805 Paper 16492765

View original record on NIH RePORTER →